Cyclica’s technology bridges computational chemistry; structural and systems biology in drug discovery. Ligand ExpressTM, a SaaS solution identifies known interactions of small molecule drugs with known protein structures used to rationalize the mechanism of drug action and reduce the risk of drug development projects by identifying on and off target drug protein docking sites. The market is the North American biopharmaceutical producers.